Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Z Shahrokh

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Pharmaceutical Research|April 1, 1994
Chromatographic methods for quantitative analysis of native, denatured, and aggregated basic fibroblast growth factor in solution formulationsV Sluzky, Z Shahrokh, P Stratton, et al.
Pharmaceutical Development and Technology|February 12, 2000
Assessment of the myotoxicity of pharmaceutical buffers using an in vitro muscle model: effect of pH, capacity, tonicity, and buffer typeJ Napaporn, M Thomas, K A Svetic, et al.
International Journal of Pharmaceutics|March 21, 2000
Modulating pharmacokinetics of an anti-interleukin-8 F(ab')(2) by amine-specific PEGylation with preserved bioactivityI L Koumenis, Z Shahrokh, S Leong, et al.
Pharmaceutical Biotechnology|January 1, 1996
Characterization, stability, and formulations of basic fibroblast growth factorY J Wang, Z Shahrokh, S Vemuri, et al.
European Journal of Biochemistry|June 1, 1992
A novel photoactivatable cross-linker for the functionally-directed region-specific fluorescent labeling of proteinsB J Thevenin, Z Shahrokh, R L Williard, et al.
Pharmaceutical Research|July 1, 1994
Major degradation products of basic fibroblast growth factor: detection of succinimide and iso-aspartate in place of aspartateZ Shahrokh, G Eberlein, D Buckley, et al.
Journal of Pharmaceutical Sciences|February 1, 1996
Flux measurements across Caco-2 monolayers may predict transport in human large intestinal tissueW Rubas, M E Cromwell, Z Shahrokh, et al.
Biochemistry|March 31, 1992
Conformational changes in the foot protein of the sarcoplasmic reticulum assessed by site-directed fluorescent labelingJ J Kang, A Tarcsafalvi, A D Carlos, et al.
Pharmaceutical Research|May 1, 1998
Stability of alkoxycarbonylamidine prodrugsZ Shahrokh, E Lee, A G Olivero, et al.
The Journal of Clinical Investigation|July 20, 1999
Safety and antitumor activity of recombinant soluble Apo2 ligandA Ashkenazi, R C Pai, S Fong, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Pharmaceutical Research|April 1, 1994
Chromatographic methods for quantitative analysis of native, denatured, and aggregated basic fibroblast growth factor in solution formulationsV Sluzky, Z Shahrokh, P Stratton, et al.
Pharmaceutical Development and Technology|February 12, 2000
Assessment of the myotoxicity of pharmaceutical buffers using an in vitro muscle model: effect of pH, capacity, tonicity, and buffer typeJ Napaporn, M Thomas, K A Svetic, et al.
International Journal of Pharmaceutics|March 21, 2000
Modulating pharmacokinetics of an anti-interleukin-8 F(ab')(2) by amine-specific PEGylation with preserved bioactivityI L Koumenis, Z Shahrokh, S Leong, et al.
Pharmaceutical Biotechnology|January 1, 1996
Characterization, stability, and formulations of basic fibroblast growth factorY J Wang, Z Shahrokh, S Vemuri, et al.
European Journal of Biochemistry|June 1, 1992
A novel photoactivatable cross-linker for the functionally-directed region-specific fluorescent labeling of proteinsB J Thevenin, Z Shahrokh, R L Williard, et al.
Pharmaceutical Research|July 1, 1994
Major degradation products of basic fibroblast growth factor: detection of succinimide and iso-aspartate in place of aspartateZ Shahrokh, G Eberlein, D Buckley, et al.
Journal of Pharmaceutical Sciences|February 1, 1996
Flux measurements across Caco-2 monolayers may predict transport in human large intestinal tissueW Rubas, M E Cromwell, Z Shahrokh, et al.
Biochemistry|March 31, 1992
Conformational changes in the foot protein of the sarcoplasmic reticulum assessed by site-directed fluorescent labelingJ J Kang, A Tarcsafalvi, A D Carlos, et al.
Pharmaceutical Research|May 1, 1998
Stability of alkoxycarbonylamidine prodrugsZ Shahrokh, E Lee, A G Olivero, et al.
The Journal of Clinical Investigation|July 20, 1999
Safety and antitumor activity of recombinant soluble Apo2 ligandA Ashkenazi, R C Pai, S Fong, et al.
Pageof 3